Skip to main content
SpringerLink
Log in

Anaplastic lymphoma kinase inhibitors: case report

Multiple drug resistance: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ouseph MM, et al. TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations. Lung Cancer: Targets and Therapy 10: 81-86, 15 Aug 2019. Available from: URL: http://doi.org/10.2147/LCTT.S212406 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anaplastic lymphoma kinase inhibitors: case report. Reactions Weekly 1778, 40 (2019). https://doi.org/10.1007/s40278-019-70843-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-70843-5

Search

Navigation